ATRA - Atara Biotherapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ATRA is currently covered by 7 analysts with an average price target of $78.77. This is a potential upside of $65.44 (490.92%) from yesterday's end of day stock price of $13.33.

Atara Biotherapeutics's activity chart (see below) currently has 63 price targets and 71 ratings on display. The stock rating distribution of ATRA is 50% BUY, 22.22% SELL and 27.78% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.74% with an average time for these price targets to be met of 60.5 days.

Highest price target for ATRA is $21, Lowest price target is $18, average price target is $78.77.

Most recent stock forecast was given by JOHN NEWMAN from CANACCORD on 13-Nov-2024. First documented stock forecast 03-Dec-2015.

Currently out of the existing stock ratings of ATRA, 9 are a BUY (50%), 4 are a SELL (22.22%), 5 are a HOLD (27.78%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$21

$11.07 (111.48%)

$13

1 months 11 days ago
(13-Nov-2024)

2/4 (50%)

$6.74 (47.27%)

59

Hold

4 months 3 days ago
(21-Aug-2024)

1/4 (25%)

$376.5 (88.90%)

175

Hold

$18

$8.07 (81.27%)

4 months 8 days ago
(16-Aug-2024)

0/4 (0%)

$10.99 (156.78%)

Sell

$35

$25.07 (252.47%)

$75

1 years 4 months 3 days ago
(21-Aug-2023)

13/13 (100%)

$-0.25 (-0.71%)

298

Sell

2 years 4 months 16 days ago
(09-Aug-2022)

3/3 (100%)

$0.54 (4.01%)

12

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ATRA (Atara Biotherapeutics) average time for price targets to be met?

On average it took 60.5 days on average for the stock forecasts to be realized with a an average price target met ratio 37.74

Which analyst has the current highest performing score on ATRA (Atara Biotherapeutics) with a proven track record?

JOHN NEWMAN

Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on ATRA

Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?

Maury Raycroft with highest potential upside - $615.07

Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?

Salveen Richter with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?